Pure Global
NCT05442372

Prevalence of HBV in Pregnancy

Prevalence of Hepatitis B Virus Infection in Pregnancy
Sohag University·ClinicalTrials.govRecruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Hepatitis B
Study type
Observational
Sponsor & location
Primary sponsor
Sohag University
Location
Sohag, Egypt
Timeline & enrollment
Phase
N/A
Start date
Jun 15, 2022
End date
Dec 15, 2022
Enrollment
200 participants
Primary outcome

HBsAg,Risk factors of HBV in pregnancy

Summary

The most common mode of HBV transmission is materno-fetal transmission mainly during labor.
 This study aims to estimate the seroprevalence of HBV infection and the possible risk factors
 of HBV acquisition in pregnant women in Upper Egypt and to evaluate the predictive value of
 HBeAg and quantitative HBsAg as surrogate markers for high viremia in pregnant women.

ICD-10 classifications
Acute hepatitis BAcute hepatitis B without delta-agent and without hepatic comaAcute delta-(super)infection in chronic hepatitis BChronic viral hepatitis B without delta-agentChronic viral hepatitis B without delta-agent : other and unspecified phase
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT05442372
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT05442372 through Pure Global AI's free database. This phase not specified trial is sponsored by Sohag University and is currently Recruiting. The study focuses on Hepatitis B. Target enrollment is 200 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.